Noninvasive assessment in the evaluation of occupational lung diseases

E. Fireman (Tel-Aviv, Israel)

Source: Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases
Session: MP8 - Noninvasive assessment in the evaluation of occupational lung diseases
Session type: Meet the Professor
Number: 2746

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Fireman (Tel-Aviv, Israel). Noninvasive assessment in the evaluation of occupational lung diseases. Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013


Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: Eur Respir Monogr 2018; 80: 222-234
Year: 2018


Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

Validation of CALIPER (Computer-aided lung informatics for pathology evaluation and rating) for the non-invasive assessment of pulmonary nodules of the adenocarcinoma spectrum
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Assessing & monitoring airway diseases using imaging
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019


Assessing & monitoring airway diseases using biomarkers
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019



Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=195
Year: 2007

Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries
Source: ERJ Open Res, 5 (4) 00182-2019; 10.1183/23120541.00182-2019
Year: 2019



Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Assessing & monitoring airway diseases using lung function
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019



Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Biometric monitoring in silicosis to detect early disease and monitor lung injury: not quite there
Source: ERJ Open Res, 2 (4) 00093-2016; 10.1183/23120541.00093-2016
Year: 2016



Biometric monitoring in silicosis to detect early disease and monitor lung injury: not quite there
Source: ERJ Open Res, 2 (4) 00086-2016; 10.1183/23120541.00086-2016
Year: 2016



Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Exercise testing in interstitial lung disease diagnosis and management
Source: Eur Respir Mon; 2009: 46: 7
Year: 2009

Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014